Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & EMBASE  
     Home | Subscribe | Feedback  

SYMPOSIUM
[View FULLTEXT] [Download PDF
 
Year : 2003  |  Volume : 49  |  Issue : 3  |  Page : 236-245  

Can We Prevent Parkinsonís and Alzheimerís Disease?

NP Kedar 
 Center for Vitamins and Cancer Research, Department of Radiology, School of Medicine,

Correspondence Address:
N P Kedar
Campus Box C-278, UCHSC, 4200 E. 9th Ave., Denver, Colorado, 80262

Parkinsonís disease (PD) and Alzheimerís (AD) are major progressive neurological disorders, the risk of which increases with advancing age (65 years and over). In familial cases, however, early onset of disease (about 35 years) is observed. In spite of extensive basic and clinical research on PD and AD, no preventive or long-term effective treatment strategies are available. Several studies have indicated that oxidative stress is a major risk factor for the initiation and progression of sporadic PD and AD. Even a-synuclein and b-amyloid fragments that are associated with the PD and AD, respectively, mediate part of their action via oxidative stress. Therefore, reducing oxidative stress appears to be a rational choice for the prevention and reduction in the rate of progression of these neurological disorders. This review provides a brief description of the epidemiology and pathogenesis of PD and AD, and the scientific rationale for the use of multiple antioxidants in the prevention of these neurological diseases.


How to cite this article:
Kedar N P. Can We Prevent Parkinsonís and Alzheimerís Disease? .J Postgrad Med 2003;49:236-245


How to cite this URL:
Kedar N P. Can We Prevent Parkinsonís and Alzheimerís Disease? . J Postgrad Med [serial online] 2003 [cited 2019 Nov 12 ];49:236-245
Available from: http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2003;volume=49;issue=3;spage=236;epage=245;aulast=Kedar;type=0


 
Tuesday, November 12, 2019
 Site Map | Home | Contact Us | Feedback | Copyright  and disclaimer